2026 Scott A. Halperin: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	81	1576	1435	29	25	455	22785
Medicine	81	16706	15716	700	665	460	22858

Overview

Scott A. Halperin is affiliated with Dalhousie University in Canada and has contributed extensively to research in the field of medicine, with a specific focus on epidemiology, infectious diseases, health, microbiology, and general health professions. Their work spans a wide range of topics including vaccine coverage and hesitancy, influenza virus research, respiratory viral infections, bacterial infections and vaccines, pneumonia and respiratory infections, SARS-CoV-2 and COVID-19 research, and viral gastroenteritis research and epidemiology.

Halperin's most recent publications include significant contributions to the understanding of respiratory and viral infections. Notable papers include:

"COVID-19 in children: the link in the transmission chain" (2020, The Lancet Infectious Diseases)
"Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial" (2021, The Lancet)
"Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons" (2024, Clinical Infectious Diseases)
"Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances" (2023, Environment International)
"Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study" (2023, The Lancet Regional Health - Americas)

The frequent coauthors who have collaborated with Scott A. Halperin throughout their research career include:

Manish Sadarangani
Julie A. Bettinger
Shaun K. Morris
Karina A. Top
Joanne M. Langley

The researcher has published predominantly in several venues known for their focus on immunization and public health, including:

Vaccine (22 publications)
Human Vaccines & Immunotherapeutics (9 publications)
PLoS ONE (6 publications)
Open Forum Infectious Diseases (4 publications)
CMAJ Open (4 publications)

Scott A. Halperin's body of work integrates considerations from vaccine effectiveness, safety, epidemiological modeling, and public health impact. Their research addresses both pediatric and adult populations and engages with current public health challenges such as COVID-19 and respiratory syncytial virus. The combined focus on immunology, infectious diseases, and epidemiology highlights cross-disciplinary approaches essential for disease prevention and control.

Best Publications

Transmission of Bordetella pertussis to young infants

Aaron M. Wendelboe;Elisabeth Njamkepo;Antoine Bourillon;D. Daniel Floret

623
Citations
Pertussis of adults and infants.

CH Wirsing von König;S Halperin;M Riffelmann;N Guiso

607
Citations
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar

527
Citations
Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary)

Anna Taddio;Mary Appleton;Robert Bortolussi;Christine Chambers

461
Citations
Morbidity of Pertussis in Adolescents and Adults

Gaston De Serres;Ramak Shadmani;Bernard Duval;Nicole Boulianne

424
Citations
The changing and dynamic epidemiology of meningococcal disease.

Scott A. Halperin;Julie A. Bettinger;Brian Greenwood;Lee H. Harrison

391
Citations
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Shelly A. McNeil;Scott A. Halperin;Joanne M. Langley;Bruce Smith

391
Citations
Inadequate pain management during routine childhood immunizations: the nerve of it.

Anna Taddio;Christine T. Chambers;Christine T. Chambers;Scott A. Halperin;Moshe Ipp

363
Citations
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Unknown

352
Citations
Reducing pain during vaccine injections: clinical practice guideline.

Anna Taddio;C. Meghan McMurtry;Vibhuti Shah;Rebecca Pillai Riddell

350
Citations
COVID-19 in children: the link in the transmission chain.

Alyson A Kelvin;Alyson A Kelvin;Scott Halperin

346
Citations
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant☆

Scott A Halperin;Gary Van Nest;Bruce Smith;Simin Abtahi

336
Citations
Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and Adolescents

Linda D. Senzilet;Scott A. Halperin;John S. Spika;Merrilyn Alagaratnam

331
Citations
Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers: A Randomized Controlled Trial

Noni E. MacDonald;Scott A. Halperin;Barbara J. Law;Bruce Forrest

296
Citations
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Matthew D. Snape;Kirsten P. Perrett;Karen J. Ford;Tessa M. John

274
Citations
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.

Tina Quanbee Tan;Tine Dalby;Kevin Forsyth;Scott A. Halperin

272
Citations
The changing age and seasonal profile of pertussis in Canada

Danuta M. Skowronski;Gaston De Serres;Diane MacDonald;Diane MacDonald;Wrency Wu

272
Citations
Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated Cases

Barbara Law;Catherine Fitzsimon;Lee Ford-Jones;Noni MacDonald

237
Citations
Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991- 1997: Report of the Immunization Monitoring Program—Active (IMPACT)

Scott A. Halperin;Elaine E. L. Wang;Barbara Law;Elaine Mills

218
Citations
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration.

M. Campins-Martí;H. K. Cheng;K. Forsyth;N. Guiso

216
Citations
Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

B. A. Halperin;A. Morris;D. MacKinnon-Cameron;J. Mutch

201
Citations

Frequent Co-Authors

David W. Scheifele University of British Columbia

Shelly A. McNeil Dalhousie University

Brian J. Ward McGill University Health Centre

Noni MacDonald Dalhousie University

Gaston De Serres Université Laval

Natasha S. Crowcroft University of Toronto

Marc Dionne Université Laval

Christine T. Chambers Dalhousie University

Volker Gerdts University of Saskatchewan

Allison McGeer University of Toronto

External Links

Wikipedia of Scott A. Halperin Personal website of Scott A. Halperin

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in exploring career options tied to Immunology, nursing pathways offer valuable opportunities. Many students seek programs that balance quality education with manageable admission criteria. For example, lpn programs with easiest admission requirements provide a practical entry point into healthcare professions, especially for those looking to gain clinical experience quickly.

Advancing further, students might consider becoming nurse practitioners. Programs like nurse practitioner programs with easy admission highlight institutions where entry barriers are lower without compromising educational standards, easing the path toward advanced practice roles in immunology-related fields.

Specializing within mental health can be another rewarding direction. The best pmhnp programs online focus on psychiatric mental health nurse practitioner training, ensuring excellent clinical placement opportunities vital for hands-on experience in patient care.

Cost is always a consideration, so it is beneficial to explore affordable pmhnp programs that maintain quality while making education more accessible. These pathways collectively support diverse career goals tied to immunology and healthcare.